Aluminum loading in preterm neonates revisited.

Area of Science:

• Neonatal Medicine
• Toxicology
• Clinical Chemistry

Background:

• Parenteral nutrition (PN) is essential for preterm neonates but carries a risk of aluminum (Al) overload.
• Aluminum contamination in PN formulations persists despite regulatory efforts by the US Food and Drug Administration (FDA).
• Preterm infants are particularly vulnerable to Al toxicity due to immature organ function.

Purpose of the Study:

• To re-evaluate aluminum exposure and balance in preterm neonates receiving total parenteral nutrition (TPN) in the NICU.
• To quantify aluminum intake versus urinary excretion to assess net retention.
• To compare measured aluminum intake against established safe limits.

Main Methods:

• Prospective study involving 10 preterm neonates in the NICU receiving TPN.
• Daily collection and analysis of PN solutions for aluminum content using atomic absorption spectrometry.
• Daily urine collection for aluminum excretion measurement and blood sampling on admission and discharge for serum aluminum levels.

Main Results:

• A significant portion, 56.2% +/- 22.7%, of administered aluminum intake was not excreted by the neonates.
• Mean serum aluminum levels decreased from 41.2 +/- 23.3 microg/L on admission to 23.5 +/- 11.2 microg/L on discharge.
• The average daily aluminum intake was 15.2 +/- 8.0 microg x kg(-1) x day(-1), approximately three times the FDA's safe limit of 5 microg x kg(-1) x day(-1).

Conclusions:

• Preterm neonates receiving TPN experience significant aluminum retention, indicating potential for cumulative toxicity.
• Current aluminum contamination levels in PN formulations exceed FDA safety guidelines for this vulnerable population.
• The observed decrease in serum aluminum levels alongside positive balance suggests tissue deposition rather than rapid elimination.